LifeTracer is not a universal life detector. Rather, it provides a foundation for interpreting complex organic mixtures. The Bennu findings remind us that life-friendly chemistry may be widespread ...

Researchers have found a way to control protein levels inside different tissues of a whole, living animal for the first time.

Bennu samples reveal biological sugars, a strange, gum-like material, and ancient stardust that shed light on the early solar ...

This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...

BioTechniques, a life science methods journal, is now accepting two new article types: Laboratory Protocols and Software ...

From “experimental archaeology” to the mysterious appeal of exploration, the wide-ranging subjects detailed in these titles captivated Smithsonian magazine’s science contributors this year ...

"Consciousness," although challenging to define, can be thought of as a first-person awareness of one's surroundings and ...

All of this might strike you as strange. Mother Nature tells you to do something that makes you miserable. And the more miserable you get, the more you do it. But Mother Nature simply doesn’t care ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbott Laboratories ABT-1.10%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.04%increase; green up pointing triangle in a deal valued at about ...